Abbott Laboratories (ABT) stock news · rev $44.33B
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
This ABT news page leads with what Abbott Laboratories filed — not a scraped headline mill.
No cached 8-K sentence for ABT yet. We will not pad this page with generic market recap.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ABT stock page; for the tape open the quote page.
ABT stock news FAQ
What are ABT's latest revenue and net income?
Latest cached Abbott Laboratories (ABT) revenue for Dec 31, 2025 was $44.33B. Net income was $6.52B. Statements: https://lician.com/financials/abt
How did ABT revenue change from the prior cached period?
Cached Abbott Laboratories (ABT) revenue was up 5.7% from $41.95B (Dec 31, 2024) to $44.33B (Dec 31, 2025). Statements: https://lician.com/financials/abt
What is ABT's market cap?
Abbott Laboratories (ABT) market cap is $154.15B on the latest cached fundamentals snapshot.
What kind of company is ABT?
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Where is ABT stock news listed?
Cached stock news for Abbott Laboratories (ABT) is listed at https://lician.com/news/abt. Filings: https://lician.com/sec/abt
Not investment advice.